77 related articles for article (PubMed ID: 18054220)
1. The in vitro immunomodulatory activity of a synthetic brassinosteroid analogue would account for the improvement of herpetic stromal keratitis in mice.
Michelini FM; Berra A; Alché LE
J Steroid Biochem Mol Biol; 2008 Jan; 108(1-2):164-70. PubMed ID: 18054220
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antiherpetic activity of three new synthetic brassinosteroid analogues.
Michelini FM; Ramírez JA; Berra A; Galagovsky LR; Alché LE
Steroids; 2004; 69(11-12):713-20. PubMed ID: 15579323
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory activity of an anti-HSV-1 synthetic stigmastane analog.
Michelini FM; Zorrilla P; Robello C; Alché LE
Bioorg Med Chem; 2013 Jan; 21(2):560-8. PubMed ID: 23219855
[TBL] [Abstract][Full Text] [Related]
4. Anti-herpetic and anti-inflammatory activities of two new synthetic 22,23-dihydroxylated stigmastane derivatives.
Michelini FM; Ramírez JA; Berra A; Galagovsky LR; Alché LE
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):111-6. PubMed ID: 18619833
[TBL] [Abstract][Full Text] [Related]
5. Antiviral action of synthetic stigmasterol derivatives on herpes simplex virus replication in nervous cells in vitro.
Petrera E; Níttolo AG; Alché LE
Biomed Res Int; 2014; 2014():947560. PubMed ID: 25147828
[TBL] [Abstract][Full Text] [Related]
6. Antiherpetic mode of action of (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one in vitro.
Wachsman MB; Castilla V; Talarico LB; Ramirez JA; Galagovsky LR; Coto CE
Int J Antimicrob Agents; 2004 May; 23(5):524-6. PubMed ID: 15120737
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.
Duan R; Remeijer L; van Dun JM; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):277-84. PubMed ID: 17197544
[TBL] [Abstract][Full Text] [Related]
8. Synergistic in vitro interactions between (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1.
Talarico LB; Castilla V; Ramirez JA; Galagovsky LR; Wachsman MB
Chemotherapy; 2006; 52(1):38-42. PubMed ID: 16340198
[TBL] [Abstract][Full Text] [Related]
9. A natural tetranortriterpenoid with immunomodulating properties as a potential anti-HSV agent.
Bueno CA; Barquero AA; Di Cónsoli H; Maier MS; Alché LE
Virus Res; 2009 Apr; 141(1):47-54. PubMed ID: 19162100
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells.
Li H; Zhang J; Kumar A; Zheng M; Atherton SS; Yu FS
Immunology; 2006 Feb; 117(2):167-76. PubMed ID: 16423052
[TBL] [Abstract][Full Text] [Related]
11. Nuclear translocation of NF-kappaB precedes apoptotic poly(ADP-ribose) polymerase cleavage during productive HSV-1 replication in corneal epithelial cells.
Goodkin ML; Epstein S; Asbell PA; Blaho JA
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4980-8. PubMed ID: 17962448
[TBL] [Abstract][Full Text] [Related]
12. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-depletion influences the course of murine HSV-1 keratitis.
Bauer D; Mrzyk S; van Rooijen N; Steuhl KP; Heiligenhaus A
Curr Eye Res; 2000 Jan; 20(1):45-53. PubMed ID: 10611714
[TBL] [Abstract][Full Text] [Related]
14. Lornoxicam suppresses recurrent herpetic stromal keratitis through down-regulation of nuclear factor-kappaB: an experimental study in mice.
Yin J; Huang Z; Xia Y; Ma F; Zhang LJ; Ma HH; Li Wang L
Mol Vis; 2009 Jun; 15():1252-9. PubMed ID: 19547717
[TBL] [Abstract][Full Text] [Related]
15. IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis.
Keadle TL; Usui N; Laycock KA; Miller JK; Pepose JS; Stuart PM
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):96-102. PubMed ID: 10634607
[TBL] [Abstract][Full Text] [Related]
16. Application of FGF-2 to modulate herpetic stromal keratitis.
Kim B; Lee S; Kaistha SD; Rouse BT
Curr Eye Res; 2006 Dec; 31(12):1021-8. PubMed ID: 17169840
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
19. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis.
Bauer D; Wasmuth S; Hennig M; Baehler H; Steuhl KP; Heiligenhaus A
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3188-98. PubMed ID: 19255156
[TBL] [Abstract][Full Text] [Related]
20. Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy.
Staats HF; Lausch RN
J Immunol; 1993 Jul; 151(1):277-83. PubMed ID: 8392096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
